Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced NSCLC × Thoracic × Clear all

Phase

Phase NA 3 Phase 2 3 Phase 3 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 692 Lung Neoplasms 297 Small Cell Lung Carcinoma 146 Colorectal Neoplasms 111 Melanoma 106 Neoplasms 93 Breast Neoplasms 93 Ovarian Neoplasms 92 Neoplasm Metastasis 85 Squamous Cell Carcinoma of Head and Neck 83 Stomach Neoplasms 81 Pancreatic Neoplasms 76 Carcinoma, Renal Cell 66 Triple Negative Breast Neoplasms 63 Esophageal Neoplasms 51 Endometrial Neoplasms 48 Uterine Cervical Neoplasms 47 Head and Neck Neoplasms 47 Mesothelioma, Malignant 41 Mesothelioma 41 Sarcoma 40 Prostatic Neoplasms 36 Urinary Bladder Neoplasms 34 Carcinoma, Transitional Cell 32 Colonic Neoplasms 31 Carcinoma, Hepatocellular 31 Adenocarcinoma of Lung 31 Carcinoma 26 Recurrence 21 Thyroid Neoplasms 20

Interventions

Oxaliplatin 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04043195 2025-05-28

NSCLC

University of California, San Diego

Phase 1/2 Active not recruiting

Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡